ArticleOncoTargets and therapy2015

GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma.

Junyi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.